Hikma And Civica Ship Eight Essential Injectables
Heparin To Be Followed By Seven Other Essential Injectable Medicines
Executive Summary
Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.
You may also be interested in...
Civica Rx Gets $55m Investment
Civica Rx has won an investment of $55m through a deal with the Blue Cross Blue Shield Association of US health insurance firms to create a new subsidiary that will acquire and develop generic filings to be launched in the US from 2022.
Civica Interested In Retired Or Withdrawn ANDAs
As a part of its strategy to develop its own ANDAs for essential medications, Civica has expressed interest in taking over existing ANDAs that are being retired or withdrawn by other generics manufacturers.
California Plans To Create Own Generics Label
California’s 2020-2021 fiscal budget includes plans to work with manufacturers to establish the state’s own generics label. But industry is sceptical that the initiative will deliver the savings that the US state hopes for.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests:
